AVAV Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Strategic Outlook ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds POLA Q1 2026 Earnings Loss Per Share of 005 Stock Declines 571 Diebold Nixdorf Q1 2026 Earnings EPS Beat Drives Stock Gains Amid Revenue Disclosure Gaps BBLG Q1 2026 Earnings NarrowerthanExpected Loss as Bone Biologics Advances Development QUAD Q1 2026 Earnings EPS Beats Estimates by 14 Stock Climbs Marginally